Search research articles
Contact Us
Filters
Showing results (101-110 of 169) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2001
Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer
G Konecny, M Untch, J Arboleda, et al.
Anticancer Research
|
August 6, 2005
Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study
H J Stemmler, C Salat, H Lindhofer, et al.
Cancer
|
May 1, 1993
Enhancement of progesterone receptor levels by interferons in AE-7 endometrial cancer cells
R Angioli, M Untch, B U Sevin, et al.
Gynecologic Oncology
|
March 4, 1999
Frequency of BRCA1 mutation 5382insC in German breast cancer patients
J Backe, S Hofferbert, B Skawran, et al.
ESMO Open
|
May 29, 2026
Concordance between clinician-reported toxicities and patient-reported symptom severity in early-stage breast cancer: an analysis of the randomized phase III PANTHER trial
P Filis, X Liu, A Matikas, et al.
The International Journal of Biological Markers
|
April 14, 2000
Tumor-biological factors uPA and PAI-1 as stratification criteria of a multicenter adjuvant chemotherapy trial in node-negative breast cancer
A Prechtl, N Harbeck, C Thomssen, et al.
Cancer Research
|
November 15, 1995
Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma
P E Andreotti, I A Cree, C M Kurbacher, et al.
Cancer
|
June 1, 1993
In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell lines
R Angioli, B U Sevin, J P Perras, et al.
Cancers
|
September 13, 2025
Ribosomal RNA Degradation (RNA Disruption) in Tumour Cells: Mechanistic Insights and Potential Clinical Utility
Amadeo M Parissenti, Sanaa Noubir, Laura B Pritzker, et al.
Seminars in Oncology
|
February 1, 1996
Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer
H J Luck, C Thomssen, A duBois, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 169) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2001
Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer
G Konecny, M Untch, J Arboleda, et al.
Anticancer Research
|
August 6, 2005
Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study
H J Stemmler, C Salat, H Lindhofer, et al.
Cancer
|
May 1, 1993
Enhancement of progesterone receptor levels by interferons in AE-7 endometrial cancer cells
R Angioli, M Untch, B U Sevin, et al.
Gynecologic Oncology
|
March 4, 1999
Frequency of BRCA1 mutation 5382insC in German breast cancer patients
J Backe, S Hofferbert, B Skawran, et al.
ESMO Open
|
May 29, 2026
Concordance between clinician-reported toxicities and patient-reported symptom severity in early-stage breast cancer: an analysis of the randomized phase III PANTHER trial
P Filis, X Liu, A Matikas, et al.
The International Journal of Biological Markers
|
April 14, 2000
Tumor-biological factors uPA and PAI-1 as stratification criteria of a multicenter adjuvant chemotherapy trial in node-negative breast cancer
A Prechtl, N Harbeck, C Thomssen, et al.
Cancer Research
|
November 15, 1995
Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma
P E Andreotti, I A Cree, C M Kurbacher, et al.
Cancer
|
June 1, 1993
In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell lines
R Angioli, B U Sevin, J P Perras, et al.
Cancers
|
September 13, 2025
Ribosomal RNA Degradation (RNA Disruption) in Tumour Cells: Mechanistic Insights and Potential Clinical Utility
Amadeo M Parissenti, Sanaa Noubir, Laura B Pritzker, et al.
Seminars in Oncology
|
February 1, 1996
Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer
H J Luck, C Thomssen, A duBois, et al.
Page
of 17